TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal So many of us use our Read more…
CADCHF: ⬆️ Buy CADCHF reversed from strong support level 0.5800 Likely to rise to resistance level 0.5850 CADCHF currency pair recently reversed up once again from the strong support level 0.5800 (which has been reversing Read more…
Health care sector bankruptcy filings are continuing in the third quarter after improving in the second quarter as more companies struggle to avoid high debt obligations and litigation. The sector faced more bankruptcy filings in Read more…
USDCHF: ⬆️ Buy USDCHF reversed from support area Likely to rise to resistance level 0.8165 USDCHF currency pair reversed from the support area located between the support level 0.8000, lower daily Bollinger Band and the Read more…
GBPCAD: ⬇️ Sell GBPCAD reversed from long-term resistance level 1.8700 Likely to fall to support level 1.8500. GBPCAD currency pair recently reversed down from the resistance zone between the upper daily Bollinger Band and the Read more…
EURCAD: ⬇️ Sell EURCAD reversed from resistance zone Likely to fall to support level 1.6000 EURCAD currency pair recently reversed down from the resistance zone lying at the intersection of the upper daily Bollinger Band Read more…
Southwest Airlines has been having a bumpy ride lately. The airline decided to start charging for bags, despite being known as the airline where Bags Fly Free. Customers, unsurprisingly, were not happy. Southwest has also Read more…
Nvidia (NVDA) just posted another blowout quarterly report in Q2, silencing the bears once again. Sales and earnings blew past expectations, while it continues to fuel the AI boom with aplomb. Yet despite the stellar Read more…
On Wednesday, the FDA approved the new round of COVID-19 vaccines from Pfizer, Moderna, and Novavax for use by seniors over the age of 65. But for anyone younger than that, the FDA approval only Read more…
On Wednesday, the FDA approved the new round of COVID-19 vaccines from Pfizer, Moderna, and Novavax for use by seniors over the age of 65. But for anyone younger than that, the FDA approval only Read more…